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ABSTRACT
BACKGROUND: Oro-facial melanomas are rare malignancies of the maxillofacial region accounting for  0.5% 
 of malignancies seen in oral mucosa. This is a case series of three case reports of orofacial melanomas 
highlighting their management and outcome in our centre. 
FINDINGS: The cases reported are of three oro-facial melanomas occurring in two females and a male. The 
age range of the patients was 40-68 years. There were two cases of melanoma of the palate and gingivae and 
a single case of melanoma of the parotid gland. All the patients presented with stage IV tumours. Of the 
three cases one died within few weeks of presentation while the remaining two are alive and under review.
CONCLUSION: Orofacial melanomas are rare painless lesions which are wrongly considered non-harmful in 
our environment thus leading to late presentation and poor prognosis.
Case Report
INTRODUCTION
elanomas are melanocyte containing 
Mmalignant tumours arising from cells of neural crest origin which constitute the 
melanin pigment in the basal and suprabasal 
1layers of the epithelium.  It is more of a cutaneous 
tumour however, extracutaneous tumour are rare 
2and aggressive.  Oro-facial melanomas are rare 
malignancies of the maxillofacial region 
accounting for 0.5% of malignancies seen in oral 
3mucosa  In Nigeria oral melanomas accounts for 
4 
0.9% of all the melanomas Malignant melanomas 
could be amelanotic and this accounts for less than 
5
10% of oral melanomas.  
The most frequent site of occurrence of 
melanomas in the oral cavity are the hard palate 
6and the maxillary gingiva  but a secondary 
satellite from a cutaneous lesion may be located in 
3the tongue, parotid and tonsils  Oral malignant 
melanomas may occur with or without radial 
7growth . In some cases, melanosis (radial growth) 
6,8
may occur before the vertical growth . Oral 
malignant melanomas may be grouped into 5 
9types  which include, pigmented nodular, non-
pigmented nodular, pigmented macular, 
pigmented mixed and non pigmented mixed. The 
lesions are active biologically and are silent 
clinically presenting as hyper pigmentation of the 
1
areas involved in their early stages. 
Their colours may range from black, red, purple 
10
or gray . In contrast to cutaneous melanomas, 
primary extracutaneous malignant melanoma are 
10 
of unknown etiological and intraoral risk factors  
Treatment modalities for orofacial malignant 
melanomas include surgery with 5mm-20mm 
11margin , chemotherapy or immunotherapy and 
2
radiotherapy.  
C h e m o t h e r a p y  a n d  r a d i o t h e r a p y  a r e 
1 1 , 1 2
controversial as treatment modalities ; 
however, adjuvant radiotherapy has been 
reported to be benecial in patients with 
13, 14aggressive melanomas.   
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CASE REPORT 1
A 64- year-old female, a retired school teacher 
presented with a year history of a dark painless 
ulcerated mass on the palate. Patient claimed to 
have noticed the lesion more than a decade before 
presentation. She claimed to have visited many 
doctors who always reassured her until recently. 
A biopsy was done on a dark hyperpigmented 
palatal patch one year prior to presentation with 
d i a g n o s i s  a s  p i g m e n t e d  e p i t h e l o i d 
melanocythoma. There were no associated 
medical conditions, no history of tobacco or 
alcohol use. On clinical examination we found an 
ulcerated, nodular mass on the right side of the 
hard palate with irregular margins. 
The swelling extended from the upper right lateral 
incisor to upper last molar (buccally) and from the 
gingival margin of upper right lateral incisor to the 
soft palate (palatally) and measured about 5cm by 
3cm, and was rm in consistency. Sentinel node 
biopsy was done which came out negative. 
Computerized Tomography (CT) scan showed 
localized lesion in the right palate with features 
suggestive of malignant melanoma. 
A diagnosis of stage IV oral mucosa malignant 
melanoma was made.  She had subtotal 
maxillectomy with post surgery histology 
reafrming the malignant melanoma diagnosis.  
She was then referred to radiotherapy unit six 
weeks later where she had chemo-radiotherapy. 
Four years after surgery patient is still clinically 
free from the tumor and was fully rehabilitated 
with an obturator .
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Figure 1: Patient with the tumour pre-surgery
Figure 2: CT-Scan of patient 1
Figure 3: Patient 1 post surgery. Dark area 
inside is the skin graft laid after maxillectomy
Figure 4: Post surgical obturator rehabilitation of 
patient 1
CASE REPORT TWO
 A 68year old female who presented to the casualty 
with left sided facial pain x 5/7 and left facial 
swelling of a year duration. The swelling was 
initially painless but became painful with 
increasing size. Pain radiates to the ipsilateral ear, 
cervical and clavicular area. 
There was history of repeated surgical excision of 
a nodular scalp lesion long before the appearance 
of the facial swelling.  There was no history of 
alcohol or tobacco use. On examination, the 
elderly woman in obvious painful distress with a 
parotid swelling measuring 8cm  x 6cm in 
diameter. There were multiple rm nodular 
masses measuring about 2cm x 1.5cm each on left 
side of the scalp with a single nodular mass on the 
right side of the scalp. 
There was slight ipsilateral tenderness over the 
stenocleidomastoid muscles and mid clavicular 
area with enlarged cervical lymph nodes which 
were matted together. The patient's blood 
pressure was 170/90mmHg with a pulse rate of 
86b/min. An impression of left sided facial pain 
?Nerve compression by mitotic lesion was made. 
Pain was controlled using strong analgesics and 
blood pressure was brought under control by the 
medical team. 
Computer tomography (CT) scan showed a 
parotid mass with an impression suggestive of 
pleomorphic adenoma. Chest x-ray showed a 
clinically clear chest with no mitotic lesion. 
Incisional biopsy of the lesion and cervical node 
was done and diagnosis of malignant melanoma 
w i t h  p o s i t i v e  n o d e s  w a s  m a d e .  L e f t 
partiodectomy without preservation of facial 
nerve with neck dissection was done after 
obtaining informed consent.  
Scalp lesion was also excised. Patient was 
discharged few days later and was referred for 
chemo-radiotherapy after 6 weeks. However, 
patient is still awaiting radiotherapy. Six months 
after surgery, no obvious sign of reoccurrence has 
been noted. 
CASE REPORT 3 
A 40year man who presented to the clinic with 
7months history of palatal swelling that bled 
spontaneously and had been increasing in size. On 
examination, we noted a black midline nodular 
mass from the posterior margin of the hard palate 
measuring about and 7cm x 4cm in diameter and 
extending anteriorly to the upper incisors. The 
mass was painless, ulcerated and bled on touch. 
There were multiple bilateral nodular lesions in 
the neck suggestive of metastatic lymph nodes.  
The cervical lymph nodes were enlarged, xed 
and matted together. Patient appeared weak and 
was admitted for resuscitation and further 
treatment. There were positive mitotic lesions 
noted on the chest x-ray. Biopsy of the lesion 
revealed a malignant melanoma. Patient was 
referred to the palliative care unit for further 
management. Unfortunately, patient died few 
weeks after presentation. 
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Figure 5: Photomicrograph of Oral melanoma 
showing mucosal epithelium (periphery), 
junctional activity and deposits of brownish 
d a r k  p i g m e n t s  ( H e m a t o x y l i n - E o s i n , 
magnication x4) of Patient 2
older patients as compared to patients under 
60years though, one patient in our report was  
40years old. The parotid melanoma was a 
secondary lesion from the scalp melanoma and 
19
this was in agreement with Gao et al  report that 
noted parotid gland melanomas to be mainly 
metastatic, usually originating from primaries in 
the skin of the head and neck. 
Two patients underwent surgery with neck 
dissection in one patient as a result of positive neck 
nodes. Elective neck dissection as been advocated 
20in management oro-facial melanomas , however, 
there are controversies in management of 
21, 22clinically negative neck nodes.  One patient had 
post-operative radiotherapy which appears to be 
very useful as there are no signs of recurrence 
more than four years post operatively, this agrees 
13 14
with ndings of Teman et al  and Ballo et al  
which suggested that adjuvant radiotherapy may 
be useful in the management of malignant 
melanoma. Orofacial malignant melanoma's 
22, 23
overall survival rate is poor.  
24
Trapp et al  noted that poor prognosis is 
associated with late diagnosis. Patients usually 
present with advanced stage of the lesion and 
sometimes with metastases as seen in our cases 
with one patient dying within weeks of 
presentation as a result of late diagnosis.
In conclusion, Orofacial melanomas are rare in our 
environment and are often considered as non-
harmful lesions leading to late presentation with 
increased chances of mortality. Adjuvant 
radiotherapy appears to be useful in reducing the 
chances of recurrence as was seen in one of our 
cases.
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Figure 6: Patient 3 with palatal malignant melanoma
Figure 7: Photomicrograph of Oral melanoma 
showing mucosal epithelium (upper periphery), 
large malignant melanocytes in junctional 
activity and deposits of brownish dark pigments 
in subepithelial stroma (Hematoxylin-Eosin, 
magnication x40)
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